Meyka Pro banner
Kodiak Sciences Inc.

Kodiak Sciences Inc. (KOD) Stock Overview

Explore Kodiak Sciences Inc.’s financial performance, market position, analyst ratings, and future outlook.

KOD●NASDAQ
HealthcareBiotechnology
$89.92
$57.57(177.96%)
U.S. Market opens in NaNh NaNm

Kodiak Sciences Inc. (KOD)

Meyka AI Score

Z

Key Financials

Market Cap5.6B
P/E Ratio-22.10
EPS (TTM)$-4.17
ROE-2.73%
Fundamental Analysis

AI Price Forecasts

1 Month$34.50
3 Months$59.87
1 Year Target$52.20

KOD Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Kodiak Sciences Inc. (NASDAQ: KOD) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Kodiak Sciences Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of KOD on the NASDAQ shows an RSI of 89.91, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $52.20 for the NASDAQ listing.

Key metrics behind Kodiak Sciences Inc.'s NASDAQ-traded stock include a P/E ratio of -22.10 and a market capitalization of 5.6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of KOD on the NASDAQ.

Price Performance (NASDAQ: KOD)

1-Day Change
177.96%
5-Day Change
163.70%
1-Month Change
138.39%
3-Month Change
150.19%
6-Month Change
143.03%
Year-to-Date (YTD) Change
221.60%
1-Year Change
468.75%
3-Year Change
4786.96%
5-Year Change
347.36%
All-Time (Max) Change
4329.56%

Contact Information

650 281 0850
1200 Page Mill Road, Palo Alto, CA, 94304

Company Facts

1,410 Employees
IPO DateOct 4, 2018
CountryUS
Actively Trading

Frequently Asked Questions